Study for the Use of the IL-6 Inhibitor Clazakizumab in Patients With Life-threatening COVID-19 Infection
Clinical trial NCT04381052 · TERMINATED
Trial details
- NCT number
- NCT04381052
- Sponsor
- Columbia University
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-18
- Primary completion
- 2021-04-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.